FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:621-622 August 23, 2001 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: A 57-year-old man presented with an ulcerative, acral–lentiginous lesion on the sole of the left foot. Pathological examination showed a melanoma (Breslow depth, 2.2 mm; Clark level IV) without involvement of the surgical margins; the dissected ilioinguinal nodes showed micrometastases. A computed tomographic (CT) scan did not show any other lesion. The patient received interferon alfa, but two years later, plantar and ilioinguinal lesions recurred. They were removed twice in five months. Therapy with interferon alfa was stopped.

Two months later, a CT scan showed bilateral metastatic lesions in the lung. The patient was treated with dacarbazine, . . . [Full Text of this Article]

References

This article has been cited by other articles:

• McWilliams, R. R., Brown, P. D., Buckner, J. C., Link, M. J., Markovic, S. N. (2003). Treatment of Brain Metastases From Melanoma. Mayo Clin Proc. 78: 1529-1536 [Abstract]  
• Tentori, L., Leonetti, C., Scarsella, M., d'Amati, G., Vergati, M., Portarena, I., Xu, W., Kalish, V., Zupi, G., Zhang, J., Graziani, G. (2003). Systemic Administration of GPI 15427, a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, Increases the Antitumor Activity of Temozolomide against Intracranial Melanoma, Glioma, Lymphoma. Clin. Cancer Res. 9: 5370-5379 [Abstract] [Full Text]  
• Ebert, B. L., Niemierko, E., Shaffer, K., Salgia, R. (2003). Use of Temozolomide with Other Cytotoxic Chemotherapy in the Treatment of Patients with Recurrent Brain Metastases from Lung Cancer. The Oncologist 8: 69-75 [Abstract] [Full Text]  
• Tentori, L., Portarena, I., Barbarino, M., Balduzzi, A., Levati, L., Vergati, M., Biroccio, A., Gold, B., Lombardi, M. L., Graziani, G. (2003). Inhibition of Telomerase Increases Resistance of Melanoma Cells to Temozolomide, but Not to Temozolomide Combined with Poly (ADP-Ribose) Polymerase Inhibitor. Mol. Pharmacol. 63: 192-202 [Abstract] [Full Text]  
• Atkins, M. B., Gollob, J. A., Sosman, J. A., McDermott, D. F., Tutin, L., Sorokin, P., Parker, R. A., Mier, J. W. (2002). A Phase II Pilot Trial of Concurrent Biochemotherapy with Cisplatin, Vinblastine, Temozolomide, Interleukin 2, and IFN-{alpha}2B in Patients with Metastatic Melanoma. Clin. Cancer Res. 8: 3075-3081 [Abstract] [Full Text]